Since it was likely that activated CD8+ T cells mediate the antitumor response observed with Ad5-TRP2/PMG5, we wished to test the hypothesis that PMG5 may promote enhanced infiltration of CD8+ T cells to the tumor site (i.e., skin peripheral to the tumor where the PM formulations were administered and/or intratumorally). Here, CD8A is linked to neoplasm.